Meanwhile, GSDME expression decreased with tumor stages (Fig. 1d) and was associated with longer overall survival (OS) (Fig. 1e) and recurrence-free survival (RFS) (Fig. 1f) in patients with CRC. The gene discussed is GSDME; the disease is neoplasm.